Information  X 
Enter a valid email address

Mereo Biophma PLC GBP0.003 (MPH)

Date Time Source Announcement
24 Apr 2019 2:30 pm
RNS
Admission to Trading
23 Apr 2019 2:25 pm
RNS
Completion of Merger
18 Apr 2019 7:00 am
RNS
Merger Update
15 Apr 2019 7:00 am
RNS
Successful end of Phase 2 Meeting with FDA
21 Mar 2019 7:00 am
RNS
Publication of Form F-4
15 Mar 2019 11:45 am
RNS
Update on Proposed Combination of Mereo & OncoMed
13 Mar 2019 11:00 am
RNS
Mereo CEO appointed NED of Elanco Animal Health
06 Mar 2019 7:00 am
RNS
Block Listing Interim Review
05 Mar 2019 1:32 pm
RNS
Mereo to present at Cowen and Company Conference
22 Feb 2019 1:50 pm
RNS
Update on Proposed Transaction with OncoMed
11 Feb 2019 7:00 am
RNS
Board Change
25 Jan 2019 11:10 am
RNS
Publication of F-4
18 Jan 2019 7:00 am
RNS
New Deferred Bonus Plan
15 Jan 2019 7:00 am
RNS
BGS-649 Phase 2b data to be Presented at ENDO 2019
27 Dec 2018 10:02 am
RNS
Director/PDMR Shareholding
24 Dec 2018 7:00 am
RNS
Director/PDMR Shareholding
18 Dec 2018 7:00 am
RNS
Positive results from safety extension study
17 Dec 2018 6:25 pm
RNS
Positive results from safety extension study
  3:44 pm
RNS
AIM Rule 17 Disclosure Statement
10 Dec 2018 7:00 am
RNS
Presentation at BMO Healthcare Conference
05 Dec 2018 1:09 pm
RNS
Proposed combination of Mereo and OncoMed
26 Nov 2018 7:00 am
RNS
Issue of Warrants
05 Nov 2018 7:00 am
RNS
First patient dosed in Phase 2 study
31 Oct 2018 3:37 pm
RNS
Total Voting Rights
15 Oct 2018 7:00 am
RNS
Completion of Patient Enrolment in Phase 2b study
01 Oct 2018 10:00 am
RNS
Revised Credit Facility and Issue of Warrants
03 Sep 2018 7:00 am
RNS
Block Listing Application
31 Aug 2018 6:25 pm
RNS
Correction to Issued Share Capital
08 Aug 2018 7:00 am
RNS
Mereo BioPharma Interim Results 2018
23 Jul 2018 7:00 am
RNS
Exercise of Options
  7:00 am
RNS
Notice of Interim Results
21 Jun 2018 12:52 pm
RNS
Result of Annual General Meeting
29 May 2018 7:00 am
RNS
Successful Completion of PrimaryBid Offer
25 May 2018 4:31 pm
RNS
PrimaryBid.com Offer
22 May 2018 7:00 am
RNS
Notice of AGM
27 Apr 2018 7:00 am
RNS
Grant of Options
26 Apr 2018 7:00 am
RNS
Update on Offering & Application to List on Nasdaq
09 Apr 2018 11:34 am
RNS
Offering and Application to List on Nasdaq
06 Apr 2018 1:03 pm
RNS
Result of General Meeting
03 Apr 2018 7:00 am
RNS
Publication of Annual Report
26 Mar 2018 7:00 am
RNS
Mereo BioPharma Files for Proposed Global Offering
23 Mar 2018 7:00 am
RNS
Final Results
20 Mar 2018 7:00 am
RNS
Mereo selected for oral presentation at ATS 2018
  7:00 am
RNS
PUBLICATION OF NOTICE OF GENERAL MEETING
19 Mar 2018 7:00 am
RNS
Mereo: Positive Top-Line Results for BGS-649
26 Feb 2018 7:00 am
RNS
Mereo BioPharma Appoints Wills Hughes-Wilson
02 Jan 2018 7:00 am
RNS
�10m credit facility drawdown & issue of warrants
18 Dec 2017 7:00 am
RNS
Mereo Plans to Conduct Registered IPO in the US
13 Dec 2017 7:00 am
RNS
Mereo BioPharma: Business Update
11 Dec 2017 7:00 am
RNS
Positive results from Phase 2 trial with BCT-197
13 Nov 2017 7:00 am
RNS
BPS-804 receives PRIME designation
06 Nov 2017 12:19 pm
RNS
Holding(s) in Company
30 Oct 2017 7:00 am
RNS
Mereo announces agreement with AstraZeneca
18 Sep 2017 7:00 am
RNS
Mereo to Present at Cantor Healthcare Conference
05 Sep 2017 7:00 am
RNS
Update on BGS-649 Phase 2b Study
22 Aug 2017 9:17 am
RNS
Issue of Warrants
08 Aug 2017 7:12 am
RNS
Interim Results
03 Jul 2017 7:00 am
RNS
Notice of Results
27 Jun 2017 11:23 am
RNS
Result of AGM
15 May 2017 7:00 am
RNS
Update on acumapimod Phase 2 Study
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t